The pathophysiology of anemia in cancer is complex and has been attributed to inflammation that leads to increased levels of cytokines that impair the production of hematopoietic growth factors, including erythropoietin, and the bone marrow response to erythropoietin [3]. Here, EPO is linked to anemia (phenotype).